Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy (Q48591960)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 March 2012

Language	Label	Description	Also known as
English	Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy	scientific article published on 29 March 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

0 references

clinically isolated syndrome

1 reference

based on heuristic

inferred from title

Niels Bergsland

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

Michael G Dwyer

9

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

Bianca Weinstock-Guttman

2

object named as

B Weinstock-Guttman

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

author name string

J Hagemeier

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

M Heininen-Brown

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

E Carl

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

C Kennedy

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

C Magnano

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

D Hojnacki

8

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

R Zivadinov

10

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

publication date

29 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

American Journal of Neuroradiology

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

33

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

8

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

1596-1601

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

Gray matter involvement in multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Gray matter atrophy in multiple sclerosis: a longitudinal study

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosum

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Cortical atrophy is relevant in multiple sclerosis at clinical onset.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Connecting white matter injury and thalamic atrophy in clinically isolated syndromes.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Regional grey matter atrophy in clinically isolated syndromes at presentation

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Multiple sclerosis and the accumulation of iron in the Basal Ganglia: quantitative assessment of brain iron using MRI t(2) relaxometry

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Iron deposits in multiple sclerosis and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

A Bayesian model of shape and appearance for subcortical brain segmentation

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

MRI of brain iron

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Susceptibility weighted imaging (SWI).

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Iron in chronic brain disorders: imaging and neurotherapeutic implications

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Iron, the substantia nigra and related neurological disorders

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Iron deposition and inflammation in multiple sclerosis. Which one comes first?

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3030

21 January 2018

Identifiers

10.3174/AJNR.A3030

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22460343

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48591960&oldid=2202758894"